2022 Fall Conference | V3 - Neurology Update en Español

Date Friday 10/28/22

Time 04:45 PM - 05:45 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Alberto J. Espay, MD, FAAN, Andres F. Deik Acosta Madiedo, MD, FAAN

Topic(s) General Neurology, Movement Disorders

Learning Objectives
Aprender sobre avances recientes en el diagnóstico y seguimiento de los desordenes del movimiento.
Aprender sobre avances en el manejo de desordenes de movimiento.
Aprender los resultados de ensayos clínicos publicados en 2022.
Aprender sobre avances recientes en el diagnóstico y seguimiento de los trastornos neurológicos funcionales.
Reconocer que el proceso se explicación del diagnóstico es el componente más importante para la terapia.
Aprender recientes avances en el manejo de trastornos neurológicos funcionales.

This program is available only within the virtual platform. To view, visit AAN.com/VirtualFC.

CME Available 1.00 CME credit

Core Competencies Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Non-neurologist

Teaching Styles Didactic

Program Materials

Event Timeline
04:45 PM - 05:05 PM PDT	Speaker	Movement Disorders Andres F. Deik Acosta Madiedo, MD, FAAN
05:05 PM - 05:15 PM PDT	Q&A	Movement Disorders Q&A Andres F. Deik Acosta Madiedo, MD, FAAN
05:15 PM - 05:35 PM PDT	Speaker	Functional Neurologic Disorders Alberto J. Espay, MD, FAAN
05:35 PM - 05:45 PM PDT	Q&A	Functional Neurologic Disorders Q&A Alberto J. Espay, MD, FAAN

Faculty Disclosures
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avion Pharmaceuticals. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Andres F. Deik Acosta Madiedo, MD, FAAN	Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Therapeutics. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Deik Acosta Madiedo has received research support from Teva Pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Cerevel Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Prevail Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Lundbeck Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from AskBio. The institution of Dr. Deik Acosta Madiedo has received research support from Annovis Bio. The institution of Dr. Deik Acosta Madiedo has received research support from Ono pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Amylyx therapeutics. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care.